Home |  English version |  Mappa |  Commenti |  Sondaggio |  Staff |  Contattaci Cerca nel sito  
Istituto di scienza dell'alimentazione

Torna all'elenco Contributi in rivista anno 2006

Contributo in rivista

Tipo: Articolo in rivista

Titolo: Glycated fibroblast growth factor-2 is quickly produced in vitro upon low-millimolar glucose treatment and detected in vivo in diabetic mice.

Anno di pubblicazione: 2006

Formato: Elettronico Cartaceo

Autori: Facchiano F; D'Arcangelo D; Russo K; Fogliano V; Mennella C; Ragone R; Zambruno G; Carbone V; Ribatti D; Peschle C; Capogrossi MC; Facchiano A.

Affiliazioni autori: Dipartimento di Ematologia Oncologia e Medicina Molecolare (F.F., C.P.), Istituto Superiore di Sanita` , I-00161 Roma, Italy; Laboratorio di Patologia Vascolare (F.F., D.D., K.R., M.C.C., A.F.), and Laboratorio di Biologia Molecolare e Cellulare (G.Z.), Istituto Dermopatico dell’Immacolata-IDI, Istituto di Ricovero e Cura a Carattere Scientifico, I-00167 Roma, Italy; Dipartimento di Scienza degli Alimenti (V.F., C.M.), Universita` di Napoli “Federico II”, I-80055 Portici, Italy; Dipartimento di Biochimica e Biofisica (R.R.), Seconda Universita` di Napoli, I-80138 Napoli, Italy; Istituto di Scienze dell’Alimentazione (V.C.), Consiglio Nazionale delle Ricerche, I-83100 Avellino, Italy; Dipartimento di Anatomia Umana e Istologia (D.R.), Policlinico, I-70124 Bari, Italy

Autori CNR:

  • VIRGINIA CARBONE

Lingua: inglese

Abstract: Angiogenesis impairment in hyperglycemic patients represents a leading cause of severe vascular complications of both type-1 and -2 diabetes mellitus (DM). Angiogenesis dysfunction in DM is related to glycemic control; however, molecular mechanisms involved are still unclear. Fibroblast growth factor-2 (FGF-2) is a potent angiogenic factor and, according to previous evidence, may represent a key target of molecular modifications triggered by high-sugar exposure. Therefore, the purpose of this study was to investigate whether short incubation with hyperglycemic levels of glucose affected FGF-2 and whether glucose-modified FGF-2 was detectable in vivo. Biochemical analyses carried out with SDS-PAGE, fluorescence emission, mass-spectrometry, immunoblot, and competitive ELISA experiments demonstrated that human FGF-2 undergoes a rapid and specific glycation upon 12.5-50 mm glucose exposure. In addition, FGF-2 exposed for 30 min to 12.5 mm glucose lost mitogenic and chemotactic activity in a time- and dose-dependent manner. Under similar conditions, binding affinity to FGF receptor 1 was dramatically reduced by 20-fold, as well as FGF receptor 1 and ERK-1/2 phosphorylation, and FGF-2 lost about 45% of angiogenic activity in two different in vivo angiogenic (Matrigel and chorioallantoic-membrane) assays. Such glucose-induced modification was specific, because other angiogenic growth factors, namely platelet-derived growth factor BB and placental-derived growth factor were not significantly or markedly less modified. Finally, for the first time, glycated-FGF-2 was detected in vivo, in tissues from hyperglycemic nonobese diabetic mice, in significantly higher amounts than in normoglycemic mice. In conclusion, hyperglycemic levels of glucose may strongly affect FGF-2 structure and impair its angiogenic features, and endogenous glycated-FGF-2 is present in diabetic mice, indicating a novel pathogenetic mechanism underlying angiogenesis defects in DM.

Lingua abstract: inglese

Pagine da: 2806

Pagine a: 2813

Rivista:

Molecular endocrinology Endocrine Society,
Paese di pubblicazione: Stati Uniti d'America
Lingua: inglese
ISSN: 0888-8809

Numero volume: 20

DOI: 10.1210/me.2005-0322

Referee: Sì: Internazionale

Indicizzato da:

  • ISI Web of Science (WOS) [000241553100016]
  • Scopus [2-s2.0-33751540369]

Strutture CNR:

Moduli:

 
Torna indietro Richiedi modifiche Invia per email Stampa
Home Il CNR  |  I servizi News |   Eventi | Istituti |  Focus